Michael J. Brennan, MD, Ph.D.
Managing Director
michael.brennan@psvf.com
Dr. Michael Brennan was previously a General Partner at Oxford Bioscience Partners. Prior to that, he was President and Chief
Executive Officer of Gene Logic (NASDAQ: GLGC). During Dr. Brennan’s time at Gene Logic, he built the company from a start-up
to a public company that achieved a market capitalization of over $5 billion. He raised three rounds of venture capital and led
Gene Logic to an IPO in November, 1997 and a large secondary public offering in January, 2000. Dr. Brennan’s previous experience
includes six years in the biopharmaceutical industry, where he has served as Vice President, Business Development for Boehringer
Mannheim Therapeutics. Dr. Brennan received a B.S. in Biochemistry, a Ph.D. in neurobiology and a M.D. from the University of
Witwatersrand, Johannesburg, South Africa.
